-
1
-
-
79251647799
-
Interferon-gamma links ultraviolet radiation to melanomagenesis in mice
-
Zaidi, M. R., S. Davis, F. P. Noonan, C. Graff-Cherry, T. S. Hawley, R. L. Walker, et al. 2011. Interferon-gamma links ultraviolet radiation to melanomagenesis in mice. Nature 469:548-553.
-
(2011)
Nature
, vol.469
, pp. 548-553
-
-
Zaidi, M.R.1
Davis, S.2
Noonan, F.P.3
Graff-Cherry, C.4
Hawley, T.S.5
Walker, R.L.6
-
2
-
-
82555205202
-
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma
-
Bertolotto, C., F. Lesueur, S. Giuliano, T. Strub, M. de Lichy, K. Bille, et al. 2011. A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature 480: 94-98.
-
(2011)
Nature
, vol.480
, pp. 94-98
-
-
Bertolotto, C.1
Lesueur, F.2
Giuliano, S.3
Strub, T.4
de Lichy, M.5
Bille, K.6
-
3
-
-
79953056443
-
The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset
-
Ceol, C. J., Y. Houvras, J. Jane-Valbuena, S. Bilodeau, D. A. Orlando, V. Battisti, et al. 2011. The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature 471:513-517.
-
(2011)
Nature
, vol.471
, pp. 513-517
-
-
Ceol, C.J.1
Houvras, Y.2
Jane-Valbuena, J.3
Bilodeau, S.4
Orlando, D.A.5
Battisti, V.6
-
4
-
-
79953064886
-
DHODH modulates transcriptional elongation in the neural crest and melanoma
-
White, R. M., J. Cech, S. Ratanasirintrawoot, C. Y. Lin, P. B. Rahl, C. J. Burke, et al. 2011. DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature 471:518-522.
-
(2011)
Nature
, vol.471
, pp. 518-522
-
-
White, R.M.1
Cech, J.2
Ratanasirintrawoot, S.3
Lin, C.Y.4
Rahl, P.B.5
Burke, C.J.6
-
5
-
-
80054681545
-
In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma
-
Karreth, F. A., Y. Tay, D. Perna, U. Ala, S. M. Tan, A. G. Rust, et al. 2011. In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell 147:382-395.
-
(2011)
Cell
, vol.147
, pp. 382-395
-
-
Karreth, F.A.1
Tay, Y.2
Perna, D.3
Ala, U.4
Tan, S.M.5
Rust, A.G.6
-
6
-
-
79960064599
-
miR-30b/30d regulation of GaINAc transferases enhances invasion and immunosuppression during metastasis
-
Gaziel-Sovran, A., M. F. Segura, R. Di Micco, M. K. Collins, D. Hanniford, E. V. S. de Miera, et al. 2011. miR-30b/30d regulation of GaINAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell 20:104-118.
-
(2011)
Cancer Cell
, vol.20
, pp. 104-118
-
-
Gaziel-Sovran, A.1
Segura, M.F.2
Di Micco, R.3
Collins, M.K.4
Hanniford, D.5
de Miera, E.V.S.6
-
7
-
-
84873728334
-
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
-
Das Thakur, M., F. Salangsang, A. S. Landman, W. R. Sellers, N. K. Pryer, M. P. Levesque, et al. Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance. Nature 2013;494: 251-255.
-
(2013)
Nature
, vol.494
, pp. 251-255
-
-
Das Thakur, M.1
Salangsang, F.2
Landman, A.S.3
Sellers, W.R.4
Pryer, N.K.5
Levesque, M.P.6
-
8
-
-
84867685827
-
Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation
-
Landsberg, J., J. Kohlmeyer, M. Renn, T. Bald, M. Rogava, M. Cron, et al. 2012. Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation. Nature 490:412-416.
-
(2012)
Nature
, vol.490
, pp. 412-416
-
-
Landsberg, J.1
Kohlmeyer, J.2
Renn, M.3
Bald, T.4
Rogava, M.5
Cron, M.6
-
9
-
-
84872567654
-
Dynamic interaction between Sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine
-
Kourrich, S., T. Hayashi, J. Y. Chuang, S. Y. Tsai, T. P. Su, and A. Bonci 2013. Dynamic interaction between Sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine. Cell 152:236-247.
-
(2013)
Cell
, vol.152
, pp. 236-247
-
-
Kourrich, S.1
Hayashi, T.2
Chuang, J.Y.3
Tsai, S.Y.4
Su, T.P.5
Bonci, A.6
-
10
-
-
84155163741
-
A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis
-
Al-Saif, A., F. Al-Mohanna, and S. Bohlega 2011. A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann. Neurol. 70:913-919.
-
(2011)
Ann. Neurol.
, vol.70
, pp. 913-919
-
-
Al-Saif, A.1
Al-Mohanna, F.2
Bohlega, S.3
-
11
-
-
84869234106
-
Sigma-1 receptor at the mitochondrial-associated endoplasmic reticulum membrane is responsible for mitochondrial metabolic regulation
-
Marriott, K. S. C., M. Prasad, V. Thapliyal, and H. S. Bose 2012. Sigma-1 receptor at the mitochondrial-associated endoplasmic reticulum membrane is responsible for mitochondrial metabolic regulation. J. Pharmacol. Exp. Ther. 343:578-586.
-
(2012)
J. Pharmacol. Exp. Ther.
, vol.343
, pp. 578-586
-
-
Marriott, K.S.C.1
Prasad, M.2
Thapliyal, V.3
Bose, H.S.4
-
12
-
-
84870736640
-
Sigma 1 receptor stimulation protects against oxidative damage through suppression of the ER stress responses in the human lens
-
Wang, L. X., J. A. Eldred, P. Sidaway, J. Sanderson, A. J. O. Smith, R. P. Bowater, et al. 2012. Sigma 1 receptor stimulation protects against oxidative damage through suppression of the ER stress responses in the human lens. Mech. Ageing Dev. 133:665-674.
-
(2012)
Mech. Ageing Dev.
, vol.133
, pp. 665-674
-
-
Wang, L.X.1
Eldred, J.A.2
Sidaway, P.3
Sanderson, J.4
Smith, A.J.O.5
Bowater, R.P.6
-
13
-
-
84879392732
-
Sigma-1 receptor agonist PRE084 is protective against mutant huntingtin-induced cell degeneration: involvement of calpastatin and the NF-kappa B pathway
-
Hyrskyluoto, A., I. Pulli, K. Tornqvist, T. H. Ho, L. Korhonen, and D. Lindholm 2013. Sigma-1 receptor agonist PRE084 is protective against mutant huntingtin-induced cell degeneration: involvement of calpastatin and the NF-kappa B pathway. Cell Death Dis. 4:e646.
-
(2013)
Cell Death Dis.
, vol.4
-
-
Hyrskyluoto, A.1
Pulli, I.2
Tornqvist, K.3
Ho, T.H.4
Korhonen, L.5
Lindholm, D.6
-
14
-
-
77249149392
-
Novel highly potent and selective sigma(1) receptor antagonists related to spipethiane
-
Piergentili, A., C. Amantini, F. Del Bello, M. Giannella, L. Mattioli, M. Palmery, et al. 2010. Novel highly potent and selective sigma(1) receptor antagonists related to spipethiane. J. Med. Chem. 53:1261-1269.
-
(2010)
J. Med. Chem.
, vol.53
, pp. 1261-1269
-
-
Piergentili, A.1
Amantini, C.2
Del Bello, F.3
Giannella, M.4
Mattioli, L.5
Palmery, M.6
-
15
-
-
34247864012
-
Three-dimensional culture models of normal and malignant breast epithelial cells
-
Lee, G. Y., P. A. Kenny, E. H. Lee, and M. J. Bissell 2007. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat. Methods 4:359-365.
-
(2007)
Nat. Methods
, vol.4
, pp. 359-365
-
-
Lee, G.Y.1
Kenny, P.A.2
Lee, E.H.3
Bissell, M.J.4
-
16
-
-
84863982875
-
SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors
-
Montagner, M., E. Enzo, M. Forcato, F. Zanconato, A. Parenti, E. Rampazzo, et al. 2012. SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors. Nature 487:380-384.
-
(2012)
Nature
, vol.487
, pp. 380-384
-
-
Montagner, M.1
Enzo, E.2
Forcato, M.3
Zanconato, F.4
Parenti, A.5
Rampazzo, E.6
-
17
-
-
27144537768
-
Novel genes associated with malignant melanoma but not benign melanocytic lesions
-
Talantov, D., A. Mazumder, J. X. Yu, T. Briggs, Y. Q. Jiang, J. Backus, et al. 2005. Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin. Cancer Res. 11:7234-7242.
-
(2005)
Clin. Cancer Res.
, vol.11
, pp. 7234-7242
-
-
Talantov, D.1
Mazumder, A.2
Yu, J.X.3
Briggs, T.4
Jiang, Y.Q.5
Backus, J.6
-
19
-
-
84871998454
-
Effect of SMURF2 targeting on susceptibility to MEK inhibitors in melanoma
-
Smith, M. P., J. Ferguson, I. Arozarena, R. Hayward, R. Marais, A. Chapman, et al. 2013. Effect of SMURF2 targeting on susceptibility to MEK inhibitors in melanoma. J. Natl. Cancer I(105):33-46.
-
(2013)
J. Natl. Cancer
, vol.1
, Issue.105
, pp. 33-46
-
-
Smith, M.P.1
Ferguson, J.2
Arozarena, I.3
Hayward, R.4
Marais, R.5
Chapman, A.6
-
20
-
-
84884127318
-
Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers
-
Hatzivassiliou, G., J. R. Haling, H. F. Chen, K. Song, S. Price, R. Heald, et al. 2013. Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers. Nature 501:232-236.
-
(2013)
Nature
, vol.501
, pp. 232-236
-
-
Hatzivassiliou, G.1
Haling, J.R.2
Chen, H.F.3
Song, K.4
Price, S.5
Heald, R.6
-
21
-
-
84883311219
-
Allosteric activation of functionally asymmetric RAF kinase dimers
-
Hu, J. C., E. C. Stites, H. Y. Yu, E. A. Germino, H. S. Meharena, P. J. S. Stork, et al. 2013. Allosteric activation of functionally asymmetric RAF kinase dimers. Cell 154:1036-1046.
-
(2013)
Cell
, vol.154
, pp. 1036-1046
-
-
Hu, J.C.1
Stites, E.C.2
Yu, H.Y.3
Germino, E.A.4
Meharena, H.S.5
Stork, P.J.S.6
-
22
-
-
83455254767
-
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
-
Poulikakos, P. I., Y. Persaud, M. Janakiraman, X. J. Kong, C. Ng, G. Moriceau, et al. 2011. RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E). Nature 480:387-390.
-
(2011)
Nature
, vol.480
, pp. 387-390
-
-
Poulikakos, P.I.1
Persaud, Y.2
Janakiraman, M.3
Kong, X.J.4
Ng, C.5
Moriceau, G.6
-
23
-
-
84871961245
-
Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion
-
Ferguson, J., I. Arozarena, M. Ehrhardt, and C. Wellbrock 2013. Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion. Oncogene 32:86-96.
-
(2013)
Oncogene
, vol.32
, pp. 86-96
-
-
Ferguson, J.1
Arozarena, I.2
Ehrhardt, M.3
Wellbrock, C.4
-
24
-
-
78650309875
-
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
-
Johannessen, C. M., J. S. Boehm, S. Y. Kim, S. R. Thomas, L. Wardwell, L. A. Johnson, et al. 2010. COT drives resistance to RAF inhibition through MAP kinase pathway reactivation. Nature 468:968-972.
-
(2010)
Nature
, vol.468
, pp. 968-972
-
-
Johannessen, C.M.1
Boehm, J.S.2
Kim, S.Y.3
Thomas, S.R.4
Wardwell, L.5
Johnson, L.A.6
-
25
-
-
84890432985
-
p53 status determines the role of autophagy in pancreatic tumour development
-
Rosenfeldt, M. T., J. O'Prey, J. P. Morton, C. Nixon, G. MacKay, A. Mrowinska, et al. 2013. p53 status determines the role of autophagy in pancreatic tumour development. Nature 504:296-300.
-
(2013)
Nature
, vol.504
, pp. 296-300
-
-
Rosenfeldt, M.T.1
O'Prey, J.2
Morton, J.P.3
Nixon, C.4
MacKay, G.5
Mrowinska, A.6
-
26
-
-
84873809147
-
MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors
-
Jessen, W. J., S. J. Miller, E. Jousma, J. Q. Wu, T. A. Rizvi, M. E. Brundage, et al. 2013. MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors. J. Clin. Invest. 123:340-347.
-
(2013)
J. Clin. Invest.
, vol.123
, pp. 340-347
-
-
Jessen, W.J.1
Miller, S.J.2
Jousma, E.3
Wu, J.Q.4
Rizvi, T.A.5
Brundage, M.E.6
-
27
-
-
84889606709
-
A melanocyte lineage program confers resistance to MAP kinase pathway inhibition
-
Johannessen, C. M., L. A. Johnson, F. Piccioni, A. Townes, D. T. Frederick, M. K. Donahue, et al. 2013. A melanocyte lineage program confers resistance to MAP kinase pathway inhibition. Nature 504:138-142.
-
(2013)
Nature
, vol.504
, pp. 138-142
-
-
Johannessen, C.M.1
Johnson, L.A.2
Piccioni, F.3
Townes, A.4
Frederick, D.T.5
Donahue, M.K.6
|